A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading ->
A nature-based solution that could help reduce the rising global burden of disease from dengue fever is looming on the research horizon. But more studies are needed before the World Health Organization could recommend a broad scale-up of the approach, WHO’s chief scientist said on Wednesday.   WHO Chief Scientist Soumya Swaminathan summed up her conclusions […] Continue reading ->